In one month, I've diagnosed more cases of ATTR cardiomyopathy than I did in 10 years. If you don't look for it, you won't find it.

A micro-tweetorial...

What should you look for?

@HannaGaggin @frederickruberg
--unexplained mild "LVH"
--PAF that has little explanation
--spinal stenosis
--carpal tunnel
--orthostatic hypotension
--bruising
--lack of EF response to #GDMTworks
--Diuretic sensitivity
--Higher biomarkers "than they should be"
Why are biomarkers higher in amyloid? It has mainly to do with direct myocardial toxicity of the amyloid protein, and NOT congestion/ischemia in most cases.

hs-cTn is almost universally elevated.

Both NPs and hs-cTn are prognostic, regardless of their 'decoupling' from HF/MI.
I have dx'd people without HF symptoms on the basis of some of the above findings.

Think of the diagnosis, because if you don't, you won't recognize it until it's later in the process.

This is important because treatments for ATTR are most effective EARLY in the disease course.
With other treatments coming, early and definitive diagnosis is really important.

@Ron_Witteles has written a lot on the careful evaluation of possible ATTR in this excellent paper: pubmed.ncbi.nlm.nih.gov/31302046/

Remember that AL is possible with an abnormal pyrophosphate scan!

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with James Januzzi Jr MD

James Januzzi Jr MD Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @JJheart_doc

9 Nov 20
A tweetorial.

Here's an intriguing analysis just published in Diabetes Care by the great folks at @AmDiabetesAssn and @ADA_Journals. We examined concentrations of insulin-like growth factor binding protein-7 (IGFBP7) at BL and 1Y in the CANVAS study.

care.diabetesjournals.org/content/early/…

1/
Why IGFBP7? Good question.

Though IGFBP7 "looks like" an IGF binder, it is lousy at this job. But IGFBP7 has other roles: it is a cell cycle arrest biomarker in the 'senescence associated secretory phenotype'.

When cells are exposed to IGFBP7 in excess, fibrosis follows.

2/
We previously found IGFBP7 was associated with cardiac structural and functional abnormalities and outcome in patients with heart failure, but we were interested to see how it would act in patients with #T2D, such as those in CANVAS.

Why?

3/
Read 16 tweets
8 Jun 20
I just finished reading another poorly-composed position paper from a major society regarding COVID19 with recommendations based on a handful of sometimes questionable papers and have a few thoughts. 1)
The pandemic has put a terrible strain on everyone. It's been very, very difficult and very frightening. What some institutions went through will leave them scarred for years to come. All of this has left people hungry for high quality science informing treatment decisions. 2)
The desire for rapid data is understandable. But there's a dark side that many of us have observed: authors have rushed papers to publication that on any non-pandemic day would have been desk rejects, but in the current environment have been published in major/top journals. 3)
Read 7 tweets
11 Jan 19
Breaking habits in medicine can be hard. Case in point: "trending troponin to peak" in patients with MI. Why is this done? Is it useful? You might be surprised at the answer. 1/ @NinoNJ @CianPMcCarthy @MGHMedicine @MGHHMU @MGHHeartHealth @chapdoc1 @HighSTEACS @troponinpapers
2/Why "trend troponin to peak" anyhow? Most do it to "size" the infarct; specifically, the concept is that the amount of troponin efflux from necrotic tissue is proportional to the size of the infarct.

But is this true? Is it accurate?
3/In a very nice review (karger.com/Article/Fullte…) Hallen makes the important point that infarct size and troponin kinetics ARE modestly correlated (r values of 0.5-0.75), BUT best data are with STEMI. We don't need troponins to diagnose or estimate infarct size in STEMI.
Read 8 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(